Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease [Phase 1, Phase 2]
Clinical trial update on a human embryonic stem cell–derived neural precursor cell therapy for Parkinson's disease. The study is a Phase 1/2…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Effect of Food on Opicapone [Phase 1]
A Phase 1 study evaluated the effect of food on the pharmacokinetics of opicapone in Parkinson disease and has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Cholinergic Nicotinic Receptors and Cognition in PD
This update reports on a completed clinical trial investigating the role of cholinergic nicotinic receptors in cognitive function in Parkins…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: rTMS for Motor and Mood Symptoms of Parkinson's Disease [NA]
This clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) for motor and mood symptoms in Parkinson's disease; result…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease [Phase 1, Phase 2]
A randomized trial evaluating Ampyra for gait impairment in Parkinson's disease has completed Phase 1 and Phase 2 with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Mild Cognitive Impairment in Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating an intervention for Parkinson's disease with mild cognitive impairment has completed; results were posted …
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon [Phase 2]
Phase 2 trial evaluating the efficacy and tolerability of nebicapone in Parkinson disease patients with wearing-off; the study has completed…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Impact of Rehabilitation in Quality of Life in PD [NA]
A completed clinical trial update evaluating the impact of rehabilitation on quality of life in patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease. [NA]
This document summarizes a clinical trial evaluating the effectiveness of intensive rehabilitation in advanced Parkinson disease. The status…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors [Phase 4]
Phase 4 clinical trial update evaluating rotigotine versus placebo for nocturnal hypokinesia in Parkinson's disease, assessed with wearable …
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg [Phase 1]
This Phase 1 trial evaluated the steady-state effect of the investigational compound BIA 6-512 on the pharmacokinetics of a single-dose Levo…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa [Phase 2]
Phase 2 trial comparing PK/PD of IPX066 to standard carbidopa-levodopa in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes [NA]
A clinical trial evaluating magnetic resonance imaging in the diagnosis of Parkinsonian syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects [Phase 1]
A Phase 1 pharmacokinetic study compares exposure of the drug BIA 6-512 between healthy elderly and healthy young subjects.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics [Phase 1]
Phase 1 trial assessing the effect of steady-state BIA 6-512 on levodopa pharmacokinetics in Parkinson disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Effect of Food on BIA 6-512 (Trans-resveratrol) [Phase 1]
A Phase 1 study update reports on the effect of food on exposure to BIA 6-512 (trans-resveratrol) in Parkinson's disease, and the trial stat…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States [Phase 4]
A Phase 4 study evaluating the impact of carbidopa/levodopa/entacapone on quality of life in Parkinson's disease has completed and is not re…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve [Phase 4]
Phase 4 clinical trial update on dexmedetomidine and cognitive reserve with completed results related to perioperative cognitive function, d…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Tolerability and Steady-state Pharmacokinetics of BIA 6-512 [Phase 1]
Phase 1 study reports tolerability and steady-state pharmacokinetics of BIA 6-512 in Parkinson disease; trial completed.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06649751 in Parkinson's disease has completed and…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics [Phase 1]
Phase 1 trial evaluating tolerability, safety, and pharmacokinetics of four single doses of BIA 6-512 (trans-resveratrol) and its effect on …
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics [Phase 1]
Phase 1 pharmacokinetic study evaluating rising single doses of BIA 6-512 and their effect on levodopa pharmacokinetics in Parkinson disease…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study on the respiratory kinematics of cough in healthy older adults and people with Parkinson'…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa [Phase 3]
A Phase 3 trial evaluating an investigational Parkinson's disease therapy in patients not well controlled on L-dopa has completed, with spon…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Caffeine as a Therapy for Parkinson's Disease [Phase 3]
This update reports the completion of a Phase 3 clinical trial evaluating caffeine as a therapy for Parkinson's disease.